TY - JOUR T1 - <em>ERJ Open Research</em> receives its first impact factor and plans for the next step JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00608-2022 VL - 9 IS - 1 SP - 00608-2022 AU - Woo-Jung Song AU - Esther Barreiro Y1 - 2023/01/01 UR - http://openres.ersjournals.com/content/9/1/00608-2022.abstract N2 - We are proud to announce that ERJ Open Research received its first impact factor (IF) of 4.2 in the 2021 Journal Citation Reports. ERJ Open Research is an open access, original research journal of the European Respiratory Society, and a sister journal of European Respiratory Journal, European Respiratory Review and Breathe. ERJ Open Research was launched in May 2015 [1]. It was initially led by Prof. Anita K. Simonds (Imperial College London, London, UK) in 2015–2018, followed by Prof. Alyn H. Morice (University of Hull, Hull, UK) in 2018–2021. Since early January 2022, Esther Barreiro is serving the journal as the Chief Editor and Woo-Jung Song continues his role as the Deputy Chief Editor (since June 2020), and we will continue to hold these positions up until the September 2024. Readers may have observed that ERJ Open Research has continued to build on its success, and is publishing more and more high-quality research articles. This achievement has come about through the joint efforts of its authors and peer reviewers, the international editorial board, the ERS Publications Office and the ERS Publications Committee. We thank everyone whose hard work and commitment have helped ERJ Open Research to continue to grow and succeed.ERJ Open Research received its first impact factor of 4.2. We thank everyone whose commitment has helped the journal to grow and succeed. The journal will continue to contribute to the wider dissemination of relevant, robust and up-to-date knowledge. https://bit.ly/3g9X0lRWe thank Jonathan Hansen (managing editor) and Caroline Ashford-Bentley (editorial coordinator; both European Respiratory Society, Sheffield, UK) for their assistance with the figures in this editorial. ER -